so I don't generally have super long term. But if I had to pick a few things and I don't know if these qualifies super long term, hopefully, they're not super long term to related to psychedelic science and psychedelics. One would be To get to the point sooner, rather than later that the federal government, or the agencies within the federal government, like the NIMH and IH etcetera, are providing funding to scientist, doing research related to psychedelic compounds on the clinical side, on the basic side across the board. And that is a significant problem currently. Because since let's just call it 1971, the controlled substance act under the Nixon Administration, once these compounds are put into schedule 1, which means High potential for abuse, no known medical application, both of which are ridiculous for most of these compounds. It was impossible. If not, at least close to Impossible, but generally impossible to get any type of federal funding for these studies. Which meant scientists had to spend a lot of their time doing two things going to philanthropists usually for small dollar amounts, which is incredibly time-consuming. Secondly. They had to write grants Grant applications for other types of work, unrelated to their core interests of psychedelics to pay. Their salaries and ensure that they would be able to support their families while pursuing this interest in the therapeutic applications of psychedelic compounds. So they were spending a ton of time simply to ensure they had a bare minimum of funding to do small studies because that's all they could afford the other option in the last few years, especially so either High Time, Low dollar amount philanthropic Fund Raising + grants or Take money from well-funded, for-profit companies startups, and that's not intrinsically bad, but it's fast. Easy money with a lot of strings attached, generally speaking and rightly. So if I were a company, I would want certain IP Provisions. I would want may be certain types of data, exclusivity and that can get very squirrelly and start to look like big Pharma, lock down very quickly. Breaking

news update very exciting

since the recording of this episode. Dr. Matthew Johnson, professor of Psychiatry and Behavioral Sciences at Johns Hopkins. Received a u01 grant from the National Institute on drug abuse, otherwise known as Nida to study psilocybin for tobacco addiction. It's the first Grant from the US government in half a century to directly study a classic psychedelic. This is a huge deal and decades in the making. This is also been a primary hope and target of mine for the last several years and I'm super, super excited. Cited to be involved with the Hopkins team. So congratulations to Matthew in team. There are also some other folks to watch very closely been K D at Yale and others. But suffice to say that is a very exciting updates since the recording of this episode. So I would like the scientist to have a third major source of funding, which is the federal government. So that is one. I'm very heavily focused on and I'm hoping the initiative at Harvard Law School that just launched which a part of it's called Poplar the project on psychedelic law and regulation will be able to help with that, and I hope they will also be able to help with insurance reimbursement. So getting to the point where these psychedelic therapies are reimbursable. For insurance, which means a broader patient population has access because right now, even if they are rescheduled and proscribable, the therapies will be very expensive because you have preparation, you have integration. You have sessions that are safe for 28 hours in length, all of this equals expensive. So to make it available to millions of people who are suffering with say, complex, PTSD, treatment resistant, depression Etc. You need insurance reimbursement. So that is a second. Big one for me and then last but certainly not least is building a family and moving into fatherhood and being a partner to my lovely, lovely beloved and I think that will be a huge phase shift for me and TBD what that means. But those are a few of my super long term big in all caps goals.